SkinCeuticals Unveils AGE Interrupter Ultra Serum to Target Skin Laxity

SkinCeuticals has introduced the AGE Interrupter Ultra Serum, a dual-patent innovation developed to visibly lift and firm lax skin—a top concern among dermatology patients.

Skin laxity can be accelerated by collagen depletion, glycation, and post-weight-loss changes, making it a multifaceted challenge for both patients and practitioners. Clinically tested, the new serum has been shown to deliver up to an 18% improvement in skin lift within 12 weeks. The formula combines Flavo-Proxylane™, rhamnose, and gentian root extract to smooth and tighten facial and neck contours without leaving a sticky residue.

Designed to complement in-office ultrasound procedures, the serum works synergistically with SkinCeuticals AGE Interrupter Advanced Cream. Clinical trials demonstrate that, when incorporated into a comprehensive regimen, the combination can reduce visible skin sagging by up to 20%, including in patients undergoing GLP-1 therapy.

This launch addresses the rising consumer demand for non-invasive solutions to skin laxity and reflects a broader industry movement toward integrating at-home skincare with professional aesthetic treatments.